ACET

Adicet Bio (ACET)

About Adicet Bio (ACET)

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

Details

Daily high

$6.76

Daily low

$6.52

Price at open

$6.59

52 Week High

$17.44

52 Week Low

$6.41

Market cap

63.9M

Dividend yield

0.00%

Volume

54,961

Avg. volume

110,990

P/E ratio

-.37

Adicet Bio News